drugset / Trial / NCT06626620

Randomized Controlled Trial of Intravenous Magnesium Sulfate Versus Terbutaline for Children in the Management of Acute Exacerbation of Asthma

NCT06626620

RandomizedParallel-groupOpen-labelTreatment

Summary

This study aimed to fill this gap by comparing the effectiveness of intravenous magnesium sulfate versus terbutaline in children with acute asthma exacerbations, providing evidence-based guidance for clinicians in emergency settings.

Timeline

Start
2024-01-01
Primary completion
2024-09-30
Completion
2024-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Magnesium Sulfate Other / unclassified 50 mg/kg Intravenous
Subject Terbutaline Small molecule 0.4 ug/kg Intravenous

Indications